We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Abbott and AstraZeneca to Collaborate on Cholesterol Drug
Abbott and AstraZeneca to Collaborate on Cholesterol Drug
July 6, 2006
Abbott Laboratories and AstraZeneca will collaborate on the development and marketing of a combination treatment targeting three blood lipids – LDL “bad” cholesterol, HDL “good” cholesterol, and triglycerides — in a single pill.